SPRR1A and familial dilated cardiomyopathy: Beyond these targets, miR-150 has also been shown to attenuate cardiomyocyte apoptosis via suppression of SPRR1A and to mitigate post-injury remodeling, fibrosis, and inflammation—key processes in the pathophysiology of DCM [38].